PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
UTHR vs. VDE
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility

Correlation

The correlation between UTHR and VDE is 0.29, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


-0.50.00.51.00.3

Performance

UTHR vs. VDE - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in United Therapeutics Corporation (UTHR) and Vanguard Energy ETF (VDE). The values are adjusted to include any dividend payments, if applicable.

-10.00%0.00%10.00%20.00%AugustSeptemberOctoberNovemberDecember2025
10.03%
0.30%
UTHR
VDE

Key characteristics

Sharpe Ratio

UTHR:

2.35

VDE:

0.94

Sortino Ratio

UTHR:

3.06

VDE:

1.34

Omega Ratio

UTHR:

1.43

VDE:

1.17

Calmar Ratio

UTHR:

2.64

VDE:

1.21

Martin Ratio

UTHR:

12.40

VDE:

2.71

Ulcer Index

UTHR:

5.28%

VDE:

6.23%

Daily Std Dev

UTHR:

27.98%

VDE:

18.00%

Max Drawdown

UTHR:

-93.18%

VDE:

-74.16%

Current Drawdown

UTHR:

-11.05%

VDE:

-4.82%

Returns By Period

In the year-to-date period, UTHR achieves a 3.36% return, which is significantly lower than VDE's 6.47% return. Over the past 10 years, UTHR has outperformed VDE with an annualized return of 9.99%, while VDE has yielded a comparatively lower 5.62% annualized return.


UTHR

YTD

3.36%

1M

0.80%

6M

11.12%

1Y

66.49%

5Y*

31.25%

10Y*

9.99%

VDE

YTD

6.47%

1M

3.58%

6M

1.08%

1Y

15.38%

5Y*

14.52%

10Y*

5.62%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

UTHR vs. VDE — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

UTHR
The Risk-Adjusted Performance Rank of UTHR is 9494
Overall Rank
The Sharpe Ratio Rank of UTHR is 9696
Sharpe Ratio Rank
The Sortino Ratio Rank of UTHR is 9393
Sortino Ratio Rank
The Omega Ratio Rank of UTHR is 9393
Omega Ratio Rank
The Calmar Ratio Rank of UTHR is 9494
Calmar Ratio Rank
The Martin Ratio Rank of UTHR is 9494
Martin Ratio Rank

VDE
The Risk-Adjusted Performance Rank of VDE is 4646
Overall Rank
The Sharpe Ratio Rank of VDE is 4747
Sharpe Ratio Rank
The Sortino Ratio Rank of VDE is 4444
Sortino Ratio Rank
The Omega Ratio Rank of VDE is 4646
Omega Ratio Rank
The Calmar Ratio Rank of VDE is 5454
Calmar Ratio Rank
The Martin Ratio Rank of VDE is 3838
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

UTHR vs. VDE - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for United Therapeutics Corporation (UTHR) and Vanguard Energy ETF (VDE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for UTHR, currently valued at 2.35, compared to the broader market-2.000.002.002.350.94
The chart of Sortino ratio for UTHR, currently valued at 3.06, compared to the broader market-4.00-2.000.002.004.003.061.34
The chart of Omega ratio for UTHR, currently valued at 1.43, compared to the broader market0.501.001.502.001.431.17
The chart of Calmar ratio for UTHR, currently valued at 2.64, compared to the broader market0.002.004.006.002.641.21
The chart of Martin ratio for UTHR, currently valued at 12.40, compared to the broader market0.0010.0020.0012.402.71
UTHR
VDE

The current UTHR Sharpe Ratio is 2.35, which is higher than the VDE Sharpe Ratio of 0.94. The chart below compares the historical Sharpe Ratios of UTHR and VDE, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio-0.500.000.501.001.502.002.503.00AugustSeptemberOctoberNovemberDecember2025
2.35
0.94
UTHR
VDE

Dividends

UTHR vs. VDE - Dividend Comparison

UTHR has not paid dividends to shareholders, while VDE's dividend yield for the trailing twelve months is around 3.04%.


TTM20242023202220212020201920182017201620152014
UTHR
United Therapeutics Corporation
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
VDE
Vanguard Energy ETF
3.04%3.23%3.34%3.65%4.13%4.76%3.59%3.35%2.90%2.31%3.17%1.98%

Drawdowns

UTHR vs. VDE - Drawdown Comparison

The maximum UTHR drawdown since its inception was -93.18%, which is greater than VDE's maximum drawdown of -74.16%. Use the drawdown chart below to compare losses from any high point for UTHR and VDE. For additional features, visit the drawdowns tool.


-15.00%-10.00%-5.00%0.00%AugustSeptemberOctoberNovemberDecember2025
-11.05%
-4.82%
UTHR
VDE

Volatility

UTHR vs. VDE - Volatility Comparison

United Therapeutics Corporation (UTHR) has a higher volatility of 8.36% compared to Vanguard Energy ETF (VDE) at 5.39%. This indicates that UTHR's price experiences larger fluctuations and is considered to be riskier than VDE based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


4.00%6.00%8.00%10.00%12.00%14.00%AugustSeptemberOctoberNovemberDecember2025
8.36%
5.39%
UTHR
VDE
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab